1999-08-19T00:00:00
Buckinghamshire health authority has announced that it is spending a further £130,000 on beta interferon treatment this year, allowing another eight multiple sclerosis patients to be treated, doubling the number treated. Patients had protested about the limited availability of the drug in Buckinghamshire.
With a HSJ subscription you’ll unlock:
HSJ is part of Wilmington Healthcare Limited. Company number 2530185. c/o Wilmington plc, 5th Floor, 10 Whitechapel High Street, London E1 8QS. Registered in England and Wales. Company registration 30158470
Site powered by Webvision Cloud